Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Trends in antiretroviral therapy and prevalence of HIV drug resistance mutations in Sweden 1997-2011.

PloS one - 1 Jan 2013

Bontell Irene, Häggblom Amanda, Bratt Göran, Albert Jan, Sönnerborg Anders

Abstract excerpt

OBJECTIVE: Describe trends in antiretroviral treatments and drug resistance mutations among Swedish HIV-patients over time 1997-2011. METHODS: Treatment histories, viral sequences, and demographic and clinical data were retrieved from the national database InfCareHIV. All ART-experienced patients were included (N = 6537), while resistance tests were restricted to those obtained ≥90 days after ART start. This...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral
Share to HIV/AIDS drug development and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV/AIDS Research and Interventions

Share to HIV Infections

Share to HIV Research and Treatment

Share to Mutation

Share to Sweden

Source

Open in PubMed Open full text

Identifiers

PMID: 23533618
DOI: 10.1371/journal.pone.0059337
PMCID: PMC3606434

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Trends in antiretroviral therapy and prevalence of HIV drug resistance mutations in Sweden 1997-2011.PMID 23533618Read ↗

High-throughput sequencing reveals a high prevalence of pretreatment HIV-1 drug resistance in Sweden.Semantic proximity Read ↗

Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010.Semantic proximity Read ↗

Increase in transmitted drug resistance in migrants from sub-Saharan Africa diagnosed with HIV-1 in SwedenSemantic proximity Read ↗

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study CohortSemantic proximity Read ↗

The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999-2005.Semantic proximity Read ↗

Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017-2020.Semantic proximity Read ↗

Short communication: prevalence of HIV type 1 transmitted drug resistance in Slovenia: 2005-2010.Semantic proximity Read ↗

HIV-1 resistance and trend analysis in newly diagnosed patients in Belgium.Semantic proximity Read ↗

Ten years survey of primary HIV-1 resistance in Serbia: the occurrence of multiclass resistance.Semantic proximity Read ↗

2017 Update of the Drug Resistance Mutations in HIV-1.Semantic proximity Read ↗

Prevalence of antiretroviral drug resistance mutations and HIV-1 non-B subtypes in newly diagnosed drug-naïve patients in Slovenia, 2000-2004.Semantic proximity Read ↗

Recent trends and patterns in HIV ‐1 transmitted drug resistance in the United KingdomSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.